0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global MRI-Safe Neurostimulation System Market Research Report 2026
Published Date: 2026-04-08
|
Report Code: QYRE-Auto-19O17222
Home | Market Reports | Health| Health Conditions
Global MRI Safe Neurostimulation System Market Research Report 2024
BUY CHAPTERS

Global MRI-Safe Neurostimulation System Market Research Report 2026

Code: QYRE-Auto-19O17222
Report
2026-04-08
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

MRI-Safe Neurostimulation System Market

The global MRI-Safe Neurostimulation System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on MRI-Safe Neurostimulation System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
deliver neurostimulation therapy to patients while ensuring compatibility with magnetic resonance imaging (MRI) procedures. MRI machines use powerful magnets and radio waves to generate detailed images of the body's internal structures, making them invaluable in diagnosing and monitoring various medical conditions.
The North American market for MRI-Safe Neurostimulation System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for MRI-Safe Neurostimulation System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of MRI-Safe Neurostimulation System include Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global MRI-Safe Neurostimulation System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding MRI-Safe Neurostimulation System. The MRI-Safe Neurostimulation System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global MRI-Safe Neurostimulation System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist MRI-Safe Neurostimulation System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of MRI-Safe Neurostimulation System Market Report

Report Metric Details
Report Name MRI-Safe Neurostimulation System Market
Segment by Type
  • Implantable
  • Transcutaneous
by Application
  • Hospitals & Clinics
  • Diagnostic Labs and Centers
  • Ambulatory Surgical Centers
  • Research Laboratories
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for MRI-Safe Neurostimulation System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines MRI-Safe Neurostimulation System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the MRI-Safe Neurostimulation System Market report?

Ans: The main players in the MRI-Safe Neurostimulation System Market are Medtronic Inc., Cyberonics, lnc., AADCO Medical Inc., Boston Scientific, Sorin, St. Jude Medical, Biotronik, Codman & Shurtleff's, Nevro Corporation, Boston Scientific Corporation

What are the Application segmentation covered in the MRI-Safe Neurostimulation System Market report?

Ans: The Applications covered in the MRI-Safe Neurostimulation System Market report are Hospitals & Clinics, Diagnostic Labs and Centers, Ambulatory Surgical Centers, Research Laboratories

What are the Type segmentation covered in the MRI-Safe Neurostimulation System Market report?

Ans: The Types covered in the MRI-Safe Neurostimulation System Market report are Implantable, Transcutaneous

1 MRI-Safe Neurostimulation System Market Overview
1.1 Product Definition
1.2 MRI-Safe Neurostimulation System by Type
1.2.1 Global MRI-Safe Neurostimulation System Market Value by Type: 2025 vs 2032
1.2.2 Implantable
1.2.3 Transcutaneous
1.3 MRI-Safe Neurostimulation System by Application
1.3.1 Global MRI-Safe Neurostimulation System Market Value by Application: 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Labs and Centers
1.3.4 Ambulatory Surgical Centers
1.3.5 Research Laboratories
1.4 Global MRI-Safe Neurostimulation System Market Size Estimates and Forecasts
1.4.1 Global MRI-Safe Neurostimulation System Revenue 2021–2032
1.4.2 Global MRI-Safe Neurostimulation System Sales 2021–2032
1.4.3 Global MRI-Safe Neurostimulation System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 MRI-Safe Neurostimulation System Market Competition by Manufacturers
2.1 Global MRI-Safe Neurostimulation System Sales Market Share by Manufacturers (2021–2026)
2.2 Global MRI-Safe Neurostimulation System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global MRI-Safe Neurostimulation System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of MRI-Safe Neurostimulation System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of MRI-Safe Neurostimulation System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of MRI-Safe Neurostimulation System, Product Types and Applications
2.7 Global Key Manufacturers of MRI-Safe Neurostimulation System, Date of Entry into the Industry
2.8 Global MRI-Safe Neurostimulation System Market Competitive Situation and Trends
2.8.1 Global MRI-Safe Neurostimulation System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global MRI-Safe Neurostimulation System Players Market Share by Revenue
2.8.3 Global MRI-Safe Neurostimulation System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MRI-Safe Neurostimulation System Market Scenario by Region
3.1 Global MRI-Safe Neurostimulation System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global MRI-Safe Neurostimulation System Sales by Region: 2021–2032
3.2.1 Global MRI-Safe Neurostimulation System Sales by Region: 2021–2026
3.2.2 Global MRI-Safe Neurostimulation System Sales by Region: 2027–2032
3.3 Global MRI-Safe Neurostimulation System Revenue by Region: 2021–2032
3.3.1 Global MRI-Safe Neurostimulation System Revenue by Region: 2021–2026
3.3.2 Global MRI-Safe Neurostimulation System Revenue by Region: 2027–2032
3.4 North America MRI-Safe Neurostimulation System Market Facts & Figures by Country
3.4.1 North America MRI-Safe Neurostimulation System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America MRI-Safe Neurostimulation System Sales by Country (2021–2032)
3.4.3 North America MRI-Safe Neurostimulation System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe MRI-Safe Neurostimulation System Market Facts & Figures by Country
3.5.1 Europe MRI-Safe Neurostimulation System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe MRI-Safe Neurostimulation System Sales by Country (2021–2032)
3.5.3 Europe MRI-Safe Neurostimulation System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MRI-Safe Neurostimulation System Market Facts & Figures by Region
3.6.1 Asia Pacific MRI-Safe Neurostimulation System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific MRI-Safe Neurostimulation System Sales by Region (2021–2032)
3.6.3 Asia Pacific MRI-Safe Neurostimulation System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MRI-Safe Neurostimulation System Market Facts & Figures by Country
3.7.1 Latin America MRI-Safe Neurostimulation System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America MRI-Safe Neurostimulation System Sales by Country (2021–2032)
3.7.3 Latin America MRI-Safe Neurostimulation System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa MRI-Safe Neurostimulation System Market Facts & Figures by Country
3.8.1 Middle East and Africa MRI-Safe Neurostimulation System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa MRI-Safe Neurostimulation System Sales by Country (2021–2032)
3.8.3 Middle East and Africa MRI-Safe Neurostimulation System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MRI-Safe Neurostimulation System Sales by Type (2021–2032)
4.1.1 Global MRI-Safe Neurostimulation System Sales by Type (2021–2026)
4.1.2 Global MRI-Safe Neurostimulation System Sales by Type (2027–2032)
4.1.3 Global MRI-Safe Neurostimulation System Sales Market Share by Type (2021–2032)
4.2 Global MRI-Safe Neurostimulation System Revenue by Type (2021–2032)
4.2.1 Global MRI-Safe Neurostimulation System Revenue by Type (2021–2026)
4.2.2 Global MRI-Safe Neurostimulation System Revenue by Type (2027–2032)
4.2.3 Global MRI-Safe Neurostimulation System Revenue Market Share by Type (2021–2032)
4.3 Global MRI-Safe Neurostimulation System Price by Type (2021–2032)
5 Segment by Application
5.1 Global MRI-Safe Neurostimulation System Sales by Application (2021–2032)
5.1.1 Global MRI-Safe Neurostimulation System Sales by Application (2021–2026)
5.1.2 Global MRI-Safe Neurostimulation System Sales by Application (2027–2032)
5.1.3 Global MRI-Safe Neurostimulation System Sales Market Share by Application (2021–2032)
5.2 Global MRI-Safe Neurostimulation System Revenue by Application (2021–2032)
5.2.1 Global MRI-Safe Neurostimulation System Revenue by Application (2021–2026)
5.2.2 Global MRI-Safe Neurostimulation System Revenue by Application (2027–2032)
5.2.3 Global MRI-Safe Neurostimulation System Revenue Market Share by Application (2021–2032)
5.3 Global MRI-Safe Neurostimulation System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic Inc.
6.1.1 Medtronic Inc. Company Information
6.1.2 Medtronic Inc. Description and Business Overview
6.1.3 Medtronic Inc. MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Inc. MRI-Safe Neurostimulation System Product Portfolio
6.1.5 Medtronic Inc. Recent Developments/Updates
6.2 Cyberonics, lnc.
6.2.1 Cyberonics, lnc. Company Information
6.2.2 Cyberonics, lnc. Description and Business Overview
6.2.3 Cyberonics, lnc. MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cyberonics, lnc. MRI-Safe Neurostimulation System Product Portfolio
6.2.5 Cyberonics, lnc. Recent Developments/Updates
6.3 AADCO Medical Inc.
6.3.1 AADCO Medical Inc. Company Information
6.3.2 AADCO Medical Inc. Description and Business Overview
6.3.3 AADCO Medical Inc. MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AADCO Medical Inc. MRI-Safe Neurostimulation System Product Portfolio
6.3.5 AADCO Medical Inc. Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Company Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boston Scientific MRI-Safe Neurostimulation System Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 Sorin
6.5.1 Sorin Company Information
6.5.2 Sorin Description and Business Overview
6.5.3 Sorin MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sorin MRI-Safe Neurostimulation System Product Portfolio
6.5.5 Sorin Recent Developments/Updates
6.6 St. Jude Medical
6.6.1 St. Jude Medical Company Information
6.6.2 St. Jude Medical Description and Business Overview
6.6.3 St. Jude Medical MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 St. Jude Medical MRI-Safe Neurostimulation System Product Portfolio
6.6.5 St. Jude Medical Recent Developments/Updates
6.7 Biotronik
6.7.1 Biotronik Company Information
6.7.2 Biotronik Description and Business Overview
6.7.3 Biotronik MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biotronik MRI-Safe Neurostimulation System Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Codman & Shurtleff's
6.8.1 Codman & Shurtleff's Company Information
6.8.2 Codman & Shurtleff's Description and Business Overview
6.8.3 Codman & Shurtleff's MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Codman & Shurtleff's MRI-Safe Neurostimulation System Product Portfolio
6.8.5 Codman & Shurtleff's Recent Developments/Updates
6.9 Nevro Corporation
6.9.1 Nevro Corporation Company Information
6.9.2 Nevro Corporation Description and Business Overview
6.9.3 Nevro Corporation MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nevro Corporation MRI-Safe Neurostimulation System Product Portfolio
6.9.5 Nevro Corporation Recent Developments/Updates
6.10 Boston Scientific Corporation
6.10.1 Boston Scientific Corporation Company Information
6.10.2 Boston Scientific Corporation Description and Business Overview
6.10.3 Boston Scientific Corporation MRI-Safe Neurostimulation System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Boston Scientific Corporation MRI-Safe Neurostimulation System Product Portfolio
6.10.5 Boston Scientific Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MRI-Safe Neurostimulation System Industry Chain Analysis
7.2 MRI-Safe Neurostimulation System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MRI-Safe Neurostimulation System Production Mode & Process Analysis
7.4 MRI-Safe Neurostimulation System Sales and Marketing
7.4.1 MRI-Safe Neurostimulation System Sales Channels
7.4.2 MRI-Safe Neurostimulation System Distributors
7.5 MRI-Safe Neurostimulation System Customer Analysis
8 MRI-Safe Neurostimulation System Market Dynamics
8.1 MRI-Safe Neurostimulation System Industry Trends
8.2 MRI-Safe Neurostimulation System Market Drivers
8.3 MRI-Safe Neurostimulation System Market Challenges
8.4 MRI-Safe Neurostimulation System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global MRI-Safe Neurostimulation System Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global MRI-Safe Neurostimulation System Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global MRI-Safe Neurostimulation System Market Competitive Situation by Manufacturers in 2025
 Table 4. Global MRI-Safe Neurostimulation System Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global MRI-Safe Neurostimulation System Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global MRI-Safe Neurostimulation System Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global MRI-Safe Neurostimulation System Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market MRI-Safe Neurostimulation System Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of MRI-Safe Neurostimulation System, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of MRI-Safe Neurostimulation System, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of MRI-Safe Neurostimulation System, Product Types and Applications
 Table 12. Global Key Manufacturers of MRI-Safe Neurostimulation System, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global MRI-Safe Neurostimulation System Companies by Tier (Tier 1, Tier 2, Tier 3), based on MRI-Safe Neurostimulation System Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global MRI-Safe Neurostimulation System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global MRI-Safe Neurostimulation System Sales by Region (K Units), 2021–2026
 Table 18. Global MRI-Safe Neurostimulation System Sales Market Share by Region (2021–2026)
 Table 19. Global MRI-Safe Neurostimulation System Sales by Region (K Units), 2027–2032
 Table 20. Global MRI-Safe Neurostimulation System Sales Market Share by Region (2027–2032)
 Table 21. Global MRI-Safe Neurostimulation System Revenue by Region (US$ Million), 2021–2026
 Table 22. Global MRI-Safe Neurostimulation System Revenue Market Share by Region (2021–2026)
 Table 23. Global MRI-Safe Neurostimulation System Revenue by Region (US$ Million), 2027–2032
 Table 24. Global MRI-Safe Neurostimulation System Revenue Market Share by Region (2027–2032)
 Table 25. North America MRI-Safe Neurostimulation System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America MRI-Safe Neurostimulation System Sales by Country (K Units), 2021–2026
 Table 27. North America MRI-Safe Neurostimulation System Sales by Country (K Units), 2027–2032
 Table 28. North America MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2021–2026
 Table 29. North America MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe MRI-Safe Neurostimulation System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe MRI-Safe Neurostimulation System Sales by Country (K Units), 2021–2026
 Table 32. Europe MRI-Safe Neurostimulation System Sales by Country (K Units), 2027–2032
 Table 33. Europe MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific MRI-Safe Neurostimulation System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific MRI-Safe Neurostimulation System Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific MRI-Safe Neurostimulation System Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific MRI-Safe Neurostimulation System Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific MRI-Safe Neurostimulation System Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America MRI-Safe Neurostimulation System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America MRI-Safe Neurostimulation System Sales by Country (K Units), 2021–2026
 Table 42. Latin America MRI-Safe Neurostimulation System Sales by Country (K Units), 2027–2032
 Table 43. Latin America MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa MRI-Safe Neurostimulation System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa MRI-Safe Neurostimulation System Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa MRI-Safe Neurostimulation System Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa MRI-Safe Neurostimulation System Revenue by Country (US$ Million), 2027–2032
 Table 50. Global MRI-Safe Neurostimulation System Sales (K Units) by Type (2021–2026)
 Table 51. Global MRI-Safe Neurostimulation System Sales (K Units) by Type (2027–2032)
 Table 52. Global MRI-Safe Neurostimulation System Sales Market Share by Type (2021–2026)
 Table 53. Global MRI-Safe Neurostimulation System Sales Market Share by Type (2027–2032)
 Table 54. Global MRI-Safe Neurostimulation System Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global MRI-Safe Neurostimulation System Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global MRI-Safe Neurostimulation System Revenue Market Share by Type (2021–2026)
 Table 57. Global MRI-Safe Neurostimulation System Revenue Market Share by Type (2027–2032)
 Table 58. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Type (2021–2026)
 Table 59. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Type (2027–2032)
 Table 60. Global MRI-Safe Neurostimulation System Sales (K Units) by Application (2021–2026)
 Table 61. Global MRI-Safe Neurostimulation System Sales (K Units) by Application (2027–2032)
 Table 62. Global MRI-Safe Neurostimulation System Sales Market Share by Application (2021–2026)
 Table 63. Global MRI-Safe Neurostimulation System Sales Market Share by Application (2027–2032)
 Table 64. Global MRI-Safe Neurostimulation System Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global MRI-Safe Neurostimulation System Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global MRI-Safe Neurostimulation System Revenue Market Share by Application (2021–2026)
 Table 67. Global MRI-Safe Neurostimulation System Revenue Market Share by Application (2027–2032)
 Table 68. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Application (2021–2026)
 Table 69. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Application (2027–2032)
 Table 70. Medtronic Inc. Company Information
 Table 71. Medtronic Inc. Description and Business Overview
 Table 72. Medtronic Inc. MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Medtronic Inc. MRI-Safe Neurostimulation System Product
 Table 74. Medtronic Inc. Recent Developments/Updates
 Table 75. Cyberonics, lnc. Company Information
 Table 76. Cyberonics, lnc. Description and Business Overview
 Table 77. Cyberonics, lnc. MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Cyberonics, lnc. MRI-Safe Neurostimulation System Product
 Table 79. Cyberonics, lnc. Recent Developments/Updates
 Table 80. AADCO Medical Inc. Company Information
 Table 81. AADCO Medical Inc. Description and Business Overview
 Table 82. AADCO Medical Inc. MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. AADCO Medical Inc. MRI-Safe Neurostimulation System Product
 Table 84. AADCO Medical Inc. Recent Developments/Updates
 Table 85. Boston Scientific Company Information
 Table 86. Boston Scientific Description and Business Overview
 Table 87. Boston Scientific MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Boston Scientific MRI-Safe Neurostimulation System Product
 Table 89. Boston Scientific Recent Developments/Updates
 Table 90. Sorin Company Information
 Table 91. Sorin Description and Business Overview
 Table 92. Sorin MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Sorin MRI-Safe Neurostimulation System Product
 Table 94. Sorin Recent Developments/Updates
 Table 95. St. Jude Medical Company Information
 Table 96. St. Jude Medical Description and Business Overview
 Table 97. St. Jude Medical MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. St. Jude Medical MRI-Safe Neurostimulation System Product
 Table 99. St. Jude Medical Recent Developments/Updates
 Table 100. Biotronik Company Information
 Table 101. Biotronik Description and Business Overview
 Table 102. Biotronik MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Biotronik MRI-Safe Neurostimulation System Product
 Table 104. Biotronik Recent Developments/Updates
 Table 105. Codman & Shurtleff's Company Information
 Table 106. Codman & Shurtleff's Description and Business Overview
 Table 107. Codman & Shurtleff's MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Codman & Shurtleff's MRI-Safe Neurostimulation System Product
 Table 109. Codman & Shurtleff's Recent Developments/Updates
 Table 110. Nevro Corporation Company Information
 Table 111. Nevro Corporation Description and Business Overview
 Table 112. Nevro Corporation MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Nevro Corporation MRI-Safe Neurostimulation System Product
 Table 114. Nevro Corporation Recent Developments/Updates
 Table 115. Boston Scientific Corporation Company Information
 Table 116. Boston Scientific Corporation Description and Business Overview
 Table 117. Boston Scientific Corporation MRI-Safe Neurostimulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Boston Scientific Corporation MRI-Safe Neurostimulation System Product
 Table 119. Boston Scientific Corporation Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. MRI-Safe Neurostimulation System Distributors List
 Table 123. MRI-Safe Neurostimulation System Customers List
 Table 124. MRI-Safe Neurostimulation System Market Trends
 Table 125. MRI-Safe Neurostimulation System Market Drivers
 Table 126. MRI-Safe Neurostimulation System Market Challenges
 Table 127. MRI-Safe Neurostimulation System Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of MRI-Safe Neurostimulation System
 Figure 2. Global MRI-Safe Neurostimulation System Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global MRI-Safe Neurostimulation System Market Share by Type: 2025 & 2032
 Figure 4. Implantable Product Picture
 Figure 5. Transcutaneous Product Picture
 Figure 6. Global MRI-Safe Neurostimulation System Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global MRI-Safe Neurostimulation System Market Share by Application: 2025 & 2032
 Figure 8. Hospitals & Clinics
 Figure 9. Diagnostic Labs and Centers
 Figure 10. Ambulatory Surgical Centers
 Figure 11. Research Laboratories
 Figure 12. Global MRI-Safe Neurostimulation System Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global MRI-Safe Neurostimulation System Market Size (US$ Million), 2021–2032
 Figure 14. Global MRI-Safe Neurostimulation System Sales (K Units), 2021–2032
 Figure 15. Global MRI-Safe Neurostimulation System Average Price (US$/Unit), 2021–2032
 Figure 16. MRI-Safe Neurostimulation System Report Years Considered
 Figure 17. MRI-Safe Neurostimulation System Sales Share by Manufacturers in 2025
 Figure 18. Global MRI-Safe Neurostimulation System Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global MRI-Safe Neurostimulation System Players: Market Share by Revenue in MRI-Safe Neurostimulation System in 2025
 Figure 20. MRI-Safe Neurostimulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global MRI-Safe Neurostimulation System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America MRI-Safe Neurostimulation System Sales Market Share by Country (2021–2032)
 Figure 23. North America MRI-Safe Neurostimulation System Revenue Market Share by Country (2021–2032)
 Figure 24. United States MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe MRI-Safe Neurostimulation System Sales Market Share by Country (2021–2032)
 Figure 27. Europe MRI-Safe Neurostimulation System Revenue Market Share by Country (2021–2032)
 Figure 28. Germany MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific MRI-Safe Neurostimulation System Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific MRI-Safe Neurostimulation System Revenue Market Share by Region (2021–2032)
 Figure 35. China MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America MRI-Safe Neurostimulation System Sales Market Share by Country (2021–2032)
 Figure 43. Latin America MRI-Safe Neurostimulation System Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa MRI-Safe Neurostimulation System Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa MRI-Safe Neurostimulation System Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE MRI-Safe Neurostimulation System Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of MRI-Safe Neurostimulation System by Type (2021–2032)
 Figure 54. Global Revenue Market Share of MRI-Safe Neurostimulation System by Type (2021–2032)
 Figure 55. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of MRI-Safe Neurostimulation System by Application (2021–2032)
 Figure 57. Global Revenue Market Share of MRI-Safe Neurostimulation System by Application (2021–2032)
 Figure 58. Global MRI-Safe Neurostimulation System Price (US$/Unit) by Application (2021–2032)
 Figure 59. MRI-Safe Neurostimulation System Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS